JPS52154528A - Remedy for glaucoma - Google Patents

Remedy for glaucoma

Info

Publication number
JPS52154528A
JPS52154528A JP6225876A JP6225876A JPS52154528A JP S52154528 A JPS52154528 A JP S52154528A JP 6225876 A JP6225876 A JP 6225876A JP 6225876 A JP6225876 A JP 6225876A JP S52154528 A JPS52154528 A JP S52154528A
Authority
JP
Japan
Prior art keywords
remedy
glaucoma
bydrochloride
bupranolol
stenocardia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6225876A
Other languages
Japanese (ja)
Inventor
Toshio Otani
Hidefumi Kurosawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Kaken Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Kaken Chemical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP6225876A priority Critical patent/JPS52154528A/en
Priority to DE19772723936 priority patent/DE2723936A1/en
Priority to NL7705839A priority patent/NL7705839A/en
Priority to FR7716290A priority patent/FR2353295B1/fr
Priority to GB22965/77A priority patent/GB1564454A/en
Publication of JPS52154528A publication Critical patent/JPS52154528A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Abstract

PURPOSE: A remedy for glaucoma without side effects containing bupranolol bydrochloride as an effective component which is also useful as remedy for stenocardia.
COPYRIGHT: (C)1977,JPO&Japio
JP6225876A 1976-05-31 1976-05-31 Remedy for glaucoma Pending JPS52154528A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP6225876A JPS52154528A (en) 1976-05-31 1976-05-31 Remedy for glaucoma
DE19772723936 DE2723936A1 (en) 1976-05-31 1977-05-26 OPHTHALMIC SOLUTION FOR GLAUCOM TREATMENT
NL7705839A NL7705839A (en) 1976-05-31 1977-05-27 PROCESS FOR PREPARING A MEDICINAL PRODUCT AGAINST EYE DISEASES AND THE MEDICINAL PRODUCT THEREFORE.
FR7716290A FR2353295B1 (en) 1976-05-31 1977-05-27
GB22965/77A GB1564454A (en) 1976-05-31 1977-05-31 Antiglaucomatous ophtalmic solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6225876A JPS52154528A (en) 1976-05-31 1976-05-31 Remedy for glaucoma

Publications (1)

Publication Number Publication Date
JPS52154528A true JPS52154528A (en) 1977-12-22

Family

ID=13194930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6225876A Pending JPS52154528A (en) 1976-05-31 1976-05-31 Remedy for glaucoma

Country Status (5)

Country Link
JP (1) JPS52154528A (en)
DE (1) DE2723936A1 (en)
FR (1) FR2353295B1 (en)
GB (1) GB1564454A (en)
NL (1) NL7705839A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588047A (en) * 1981-06-30 1983-01-18 Merck Patent Gmbh Intraocular pressure-reducing 1-(p-2- isopropoxyethoxymethyl-phenoxy)-3-isopropylamino- propan-2-ol and ophthalmic medicine containing same
JPS59196819A (en) * 1983-02-15 1984-11-08 Simes Ophthalmic medicine composition and glaucoma therapy

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281654A (en) * 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
ES2067864T3 (en) * 1990-05-22 1995-04-01 R Tech Ueno Ltd TREATMENT OF EYE HYPERTENSION WITH A SYNERGIC COMBINATION FOR EYE ADMINISTRATION.
IT1248014B (en) * 1991-06-07 1995-01-05 Inverni Della Beffa Spa PROTRACTED OPHTHALMIC PREPARATIONS
GR1001366B (en) * 1992-10-16 1993-10-29 Inverni Della Beffa Spa Extended-release opthalmic preparations.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588047A (en) * 1981-06-30 1983-01-18 Merck Patent Gmbh Intraocular pressure-reducing 1-(p-2- isopropoxyethoxymethyl-phenoxy)-3-isopropylamino- propan-2-ol and ophthalmic medicine containing same
JPS59196819A (en) * 1983-02-15 1984-11-08 Simes Ophthalmic medicine composition and glaucoma therapy

Also Published As

Publication number Publication date
FR2353295B1 (en) 1982-11-05
FR2353295A1 (en) 1977-12-30
GB1564454A (en) 1980-04-10
DE2723936A1 (en) 1977-12-15
NL7705839A (en) 1977-12-02

Similar Documents

Publication Publication Date Title
JPS52154528A (en) Remedy for glaucoma
JPS52153947A (en) Dicyclododecyl peroxycarbonate
JPS52106844A (en) 3-cyanomethylcyclopentanone derivatives
JPS52100483A (en) Isoleucomycin a5
JPS53108974A (en) 7-arginylamino-4-methylcoumarin
JPS549273A (en) 7-arginylamono-4-methylcoumarin
JPS5346968A (en) Novel hexadecapeptides
JPS5430135A (en) 4-hydroxy-4-methyl-cyclohexene-2-one-1
JPS5392774A (en) 5,6,7,3',4',5'-hexahydrooxyflavone
JPS5346937A (en) Preparation of n-p-aminobenzoyl-n,-p-aminourea
JPS52108925A (en) Protease inhibitor
JPS5291880A (en) 3-acyl-5-fluorouracil
JPS5346955A (en) Polyoxypregnane type compound
JPS52100486A (en) Gamma-glutamic acid n-carboxyanhydride
JPS5377012A (en) Peptide
JPS52118453A (en) Indene derivatives
JPS52118461A (en) Thiophene-silylenole-ether
JPS5283708A (en) Desacyl-pepsidin
JPS537672A (en) 4-aminomethyl-5,6,7-trihydroxyisocoumarin
JPS52111554A (en) Anthracycline type compounds
JPS52148045A (en) 4-hydroxypent-2-ene-1-one derivatives
JPS5346956A (en) Nicotinoyltometogenin derivative
JPS5346957A (en) Tometogenin derivative
JPS5315326A (en) N,n,n',n'-tetraglycidyltolylenediamine
JPS52142047A (en) Phenylcyanomethylaminomethylphosphonate